Actively Recruiting
This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab
Led by AstraZeneca · Updated on 2026-04-21
1000
Participants Needed
20
Research Sites
129 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to collect empirical data that elucidates the clinical profile and therapeutic efficacy of benralizumab among the patients aged 12 years and above, with severe eosinophilic asthma. The study will focus on the early treatment response, treatment outcomes and the change in asthma control of benralizumab therapy in a real-world setting in China. This study will also describe the physician-reported reasons for discontinuation and switching of benralizumab therapy.
CONDITIONS
Official Title
This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be at least 12 years old at the time of signing informed consent
- Patients must have severe eosinophilic asthma and be prescribed benralizumab by their clinician
- Blood eosinophil count must be 6150/ul within 3 months prior or 300/ul within 1 year prior to informed consent
- Patients or their legal representative must provide signed informed consent before any study procedures
You will not qualify if you...
- Currently participating in any other clinical trial
- Known allergy or reaction to any component of benralizumab
- Any type of malignancy
- Prior or ongoing treatment with benralizumab
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 20 locations
1
Research Site
Anhui, China
Actively Recruiting
2
Research Site
Beijing, China
Actively Recruiting
3
Research Site
Binzhou, China
Actively Recruiting
4
Research Site
Guangzhou, China
Actively Recruiting
5
Research Site
Hangzhou, China
Actively Recruiting
6
Research Site
Huzhou, China
Actively Recruiting
7
Research Site
Jinan, China
Actively Recruiting
8
Research Site
Jinhua, China
Actively Recruiting
9
Research Site
Jining, China
Actively Recruiting
10
Research Site
Linyi, China
Actively Recruiting
11
Research Site
Mianyang, China
Actively Recruiting
12
Research Site
Nanchang, China
Actively Recruiting
13
Research Site
Nanjing, China
Actively Recruiting
14
Research Site
Ningbo, China
Actively Recruiting
15
Research Site
Shanghai, China
Actively Recruiting
16
Research Site
Shanxi, China
Actively Recruiting
17
Research Site
Suining, China
Actively Recruiting
18
Research Site
Weifang, China
Actively Recruiting
19
Research Site
Xi'an, China
Actively Recruiting
20
Research Site
Zhengzhou, China
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here